Arcus Biosciences (RCUS) PT Lowered to $30 at Wedbush
Tweet
Share
E-mailGet Alerts RCUS Hot Sheet
Price: $29.40 -0.54%
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
Wedbush analyst Robert Driscoll lowered the price target on Arcus Biosciences (NYSE: RCUS) to $30.00 (from $36.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Williams Companies (WMB) PT Raised to $103 at Morgan Stanley
- SmartFinancial (SMBK) PT Raised to $60 at Benchmark on Higher Valuation
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
